Deeptech factory
Innovative Biosensing Solutions
Kimialys is an innovative industrial biosensing company that leverages its proprietary K-One surface chemistry, with the mission of setting new standards in biosensing by delivering the most robust and reproducible data — empowering R&D teams worldwide to tackle ambitious projects and develop tomorrow’s diagnostics and therapeutics.
CEO : Cyril Gilbert
Creation : october 2020
Headcount : 22
Location : Paris Biotech Santé Cochin
Market(s) : Lateral Flow Assay / Point of Care testing / Drug Discovery / Bioanalysis / IVD
TECHNO / PRODUCTS
K-One is Kimialys’ proprietary technology, a surface chemistry that powers all the companies´s products and services today. It is a self-assembled monolayer (SAM) optimized for gold nanoparticles, chips, and electrodes unlocking applications once out of reach due to technological limitations and setting new standards for surface treatment in biosensing (detection, extraction, characterization).
PRODUCTS & SERVICES PORTFOLIO
APPLICATIONS
With their innovative technology K-One and their expertise, Kimialys empowers the following activities:
- LFA Development
- Companion Diagnostics Development
- Gold Nanoparticles for Bioanalysis
- K-One Sensor-chips supply
- SPR Analysis
- Antibody Selection
- K-One Gold Bioconjugates supply
BENEFITS
Kimialys opens up new possibilities in the diagnostic, pharmaceutical and life science industries, thanks to a unique combination of benefits:
– Sensitivity gains of up to x10;
– Optimal specificity (no background noise);
– Cost-reduction of the biodetection (regeant consumption reduced by 30%);
– Efficient in complex sample (serum, saliva, urine), without any difference with buffer solutions;
– Compatible with any biosensor using gold nanoparticles and biochips.
